Radiopharmaceuticals Market Research Reports & Industry Analysis
A radiopharmaceutical, which involves the use of radioactive agents in vivo to diagnose or treat specific diseases and conditions, generally consists of two components which determine its characteristics and clinical potential. The most common diagnostic molecular imaging agents use radioactive isotopes as the signal source. A radioactive isotope -- a radioisotope or radionuclide -- is a natural or artificially created isotope with an unstable nucleus that decays -- emitting alpha or beta particles, positrons, or gamma rays. As it decays, it loses mass and energy, until a stable isotope develops. For most elements, both stable and radioactive isotopes are known.
Examples of radioisotopes commonly combined with pharmaceutically-active molecules to form radiopharmaceuticals include technetium-99m, gallium-67, Iodine-123, Iodine-13, Thallium-201, Fluorine-18, and Indium-111.
A number of SPECT radiopharmaceuticals incorporate antibody and peptide formulations that can be targeted to specific tissue receptors, allowing one to discriminate healthy from diseased tissue with a high confidence level. However, the more specific the targeting agent is, the more difficult it is to interpret its position anatomically, since there are fewer landmarks.
Radiopharmaceuticals Industry Research & Market Reports
-
Global Radiopharmaceuticals Market 2025-2029
... analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, ... Read More
-
Diagnostic Radiopharmaceuticals and Contrast Media
... Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Contrast Media, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$7.5 Billion ... Read More
-
Radiopharmaceuticals
... 11.0% over the analysis period 2024-2030. SPECT Radioisotopes, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth ... Read More
-
Global Radiopharmaceuticals in Nuclear Medicine Market Growth 2025-2031
... to grow at a CAGR of 7.6% from 2025 to 2031. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be ... Read More
-
Global Diagnostic Radiopharmaceuticals Competitive Landscape Professional Research Report 2025
... gamma rays, which can be detected by medical imaging devices like gamma cameras or positron emission tomography (PET) scanners. When introduced into the body, these compounds selectively accumulate in specific organs or tissues, allowing healthcare ... Read More
-
Global Nuclear Medicine/Radiopharmaceuticals Competitive Landscape Professional Research Report 2025
... diseases. Radiopharmaceuticals are specially designed drugs that contain a radioactive material, typically a radionuclide. These radionuclides emit gamma rays or positrons, which can be detected by specialized imaging equipment such as gamma cameras or PET ... Read More
-
Global Radiopharmaceutical Competitive Landscape Professional Research Report 2025
... designed to target specific organs, tissues, or physiological processes within the body, allowing for the visualization or treatment of specific medical conditions. In diagnostic nuclear medicine procedures, radiopharmaceuticals emit gamma rays that can be detected ... Read More
-
Global Diagnostic Radiopharmaceuticals Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
... 2024 and is forecast to a readjusted size of USD 8217 million by 2031 with a CAGR of 6.7% during review period. Radiopharmaceuticals refer to a special class of drugs containing radionuclides for medical diagnosis ... Read More
-
Automated Radiosynthesis Module Market Report by Type (Fully Automated, Semi-Automated), Application (Hospitals, Diagnostic Labs, Radiology Clinics, and Others), and Region 2025-2033
... forward, IMARC Group expects the market to reach USD 59.4 Million by 2033, exhibiting a growth rate (CAGR) of 5.43% during 2025-2033. The increasing prevalence of various chronic and cardiovascular diseases, especially amongst the geriatric ... Read More
-
Global Diagnostic Radiopharmaceuticals Market Growth 2025-2031
... CAGR of 7.2% from 2025 to 2031. Radiopharmaceuticals refer to a special class of drugs containing radionuclides for medical diagnosis and treatment. Compounds or biological agents labeled with radionuclides used for medical diagnosis or treatment ... Read More
-
PET Radiopharmaceutical Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is presented from 2019 ... Read More
-
SPECT Radiopharmaceutical Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is presented from 2019 ... Read More
-
Radiopharmaceutical Therapies Market Size, Share, By Radioisotope Type (Iodine-131, Gallium-68, Technetium-99m, Zirconium 89, Copper 64, Radium 223, Fluorine 18, Lutetium-177, Rubidium-82, Indium-111, and Others), By Source (Nuclear Reactors, Cyclotrons, and Others), By Application (Oncology, Cardiology, Gastroenterology, Neurology, Nephrology and Others), By End-User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Ambulatory Surgical Centers, and Others) and By Region - Trends, Analysis and Forecast till 2034
... radiopharmaceutical therapies market involves gathering, analyzing, and interpreting information about a market, including its consumers, competitors, and overall industry trends. It helps businesses understand their target audience, identify opportunities for growth, and make informed decisions ... Read More
-
Global SPECT Radiopharmaceuticals Market Growth 2024-2030
... Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global SPECT Radiopharmaceuticals market. SPECT Radiopharmaceuticals ... Read More
-
Global Radiopharmaceuticals for Diagnosis Market Growth 2024-2030
... or tissues in the body. Through these signals, doctors can use nuclear medicine imaging equipment (such as single photon emission computed tomography (SPECT) and positron emission tomography (PET)) to detect and evaluate the presence and ... Read More
-
Nuclear Medicine & Radiopharmaceutical Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price ... Read More
-
Global Radiopharmaceutical for Nuclear Medicine Market Growth (Status and Outlook) 2024-2030
... expected to grow at a CAGR of %from 2024 to 2030. LPI (LP Information)' newest research report, the “Radiopharmaceutical for Nuclear Medicine Industry Forecast” looks at past sales and reviews total world Radiopharmaceutical for Nuclear ... Read More
-
Global Lutetium-177(Lu-177) Market Research Report 2024
... forecast period 2024-2030. North American market for Lutetium-177(Lu-177) is estimated to increase from $ 1.33 billion in 2023 to reach $ 4.25 billion by 2030, at a CAGR of 15.81% during the forecast period of ... Read More
-
Diagnostic Radiopharmaceuticals & Contrast Media Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... report on global diagnostic radiopharmaceuticals & contrast media market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global ... Read More
-
Diagnostic Radiopharmaceuticals Contrast Media Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price ... Read More
-
Global Diagnostic Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to ... Read More
-
Global Radiopharmaceutical Therapy Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various market segments, while the qualitative analysis ... Read More
-
Radiopharmaceuticals Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... report on global radiopharmaceuticals market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global radiopharmaceuticals market by segmenting ... Read More
-
Radiopharmaceutical Theranostics Market Size & Share Analysis - Growth Trends and Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 10.79% during the forecast period (2024-2029). The COVID-19 pandemic initially had a substantial impact on the radiopharmaceutical theranostics market. The pandemic caused delays and disruptions in ongoing ... Read More
-
Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030
... academic & research institute markets. The global radiopharmaceutical theranostics market is expected to reach an estimated $3.9 billion by 2030 with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market ... Read More
Research Assistance
